Watchlist Price Alert

Omnicell Inc. (OMCL)

NASDAQ: OMCL · Real-Time Price · USD

30.37

0.54 (1.81%)

At close: May 30, 2025, 3:59 PM

30.37

0.00%

After-hours: May 30, 2025, 05:38 PM EDT

1.81% (1D)

Bid	27
Market Cap	1.42B
Revenue (ttm)	1.14B
Net Income (ttm)	21.18M
EPS (ttm)	0.46
PE Ratio (ttm)	66.02
Forward PE	19.44
Analyst	Hold

Ask	32
Volume	524,497
Avg. Volume (20D)	707,711
Open	29.58
Previous Close	29.83
Day's Range	29.43 - 30.51
52-Week Range	22.66 - 55.75
Beta	0.78

About OMCL

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OMCL

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OMCL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 week ago

+5.49%

Omnicell shares are trading higher after the compa... Unlock content with Pro Subscription

3 weeks ago

-15.84%

Omnicell shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates and cut its FY25 adjusted EPS guidance.

News

1 week ago · businesswire.com

Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Expects Improved Profitability, Updates Second Quarter and Full Year 2025 Profit Outlook and Announces a New Stock Repurchase Program.

2 weeks ago · zacks.com

Omnicell's New Perioperative Clinic Setting Products May Boost Stock

OMCL unveils new offerings for the perioperative and clinic setting.

2 weeks ago · businesswire.com

Omnicell Announces New Products for Perioperative and Clinic Settings

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces New Products for Perioperative and Clinic Settings.

2 weeks ago · businesswire.com

Omnicell Opens New Innovation Lab in Austin, Texas

AUSTIN, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced the opening of its I...

3 weeks ago · seekingalpha.com

Omnicell: Facing New Headwinds

Omnicell, Inc., a small cap medical technology solutions provider, posted its Q1 results Tuesday. Both top and the bottom-line results beat the consensus. However, thanks to some new headlines and re...

3 weeks ago · zacks.com

Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up

OMCL posts better-than-expected top and bottom-line results for the first quarter of 2025.

3 weeks ago · seekingalpha.com

Omnicell, Inc. (OMCL) Q1 2025 Earnings Conference Call Transcript

Omnicell, Inc. (NASDAQ:OMCL ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - SVP, IR Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta -...

3 weeks ago · zacks.com

Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates

Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago.